Interferon-ë rs12979860CC genotype predicts sustained virological response to therapy in patients with chronic hepatitis C Genotype 4 but enhances hepatic fibrosis

Monocyte Chemoattractant Protein-1 as a Diagnostic Marker for Detection of Hepatocellular Carcinoma in Egypt

INTERLEUKIN 28B GENE POLYMORPHISMS AS A PREDICTOR OF TREATMENT RESPONSE IN EGYPTIANS WITH CHRONIC HEPATITIS C.

Biochemical evaluation of the combination of Pegylated IFN-α2b and Ribavarin therapy of Egyptian patients suffering from Hepatitis C Virus

Interferon Therapy For Elderly Egyptian Patients With Chronic Hepatitis C of Genotype 4

Molecular study of hepcidin in chronic hepatitis C genotype 4 patients treated with pegylated interferon/ribavirin with vitamin D

Genetic Polymorphisms of Monocyte Chemotactic Protein-1 and Risk of Spontaneous Bacterial Peritonitis in Post Hepatitis C Cirrhotic Patients

Pegylated Interferon Alfa 2a and Small Dose Ribavirin in The Treatment of HCV Genotype 4 in End-stage Renal Disease

Serum Inducible Protein -10 chemokine as a biomarker for clearance of HCV with and without treatment in Egyptian patients

Interferon-Lambda 4 Gene Polymorphisms Predict Treatment Response in Egyptian HCV Genotype 4 Patients Exposed to Radiation